We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Therapeutic Avenue for Parkinson's Disease?

News   Jan 24, 2018 | Original story from Buck Institute

 
Therapeutic Avenue for Parkinson's Disease?

In post-mortem samples from individuals with Parkinson's, brain cells called astrocytes show evidence of cellular senescence. Senescent cells loose a specific protein from their nuclei; this protein is indicated with the green signal in the image above. This protein is lost from astrocytes (red cells), but not from neighboring cells. Note that astrocytes do not appear to become senescent in control individuals -- on the left. Credit: Georgia Woods, PhD Buck Institute for Research on Aging

 
 
 

RELATED ARTICLES

670,000 Person Study Suggests Sex Differences and Autistic Traits Have Impacts on Cognitive Empathy

News

Scientists have completed the world’s largest ever study of typical sex differences and autistic traits, involving well over half a million people. They tested and confirmed two long-standing psychological theories: the Empathising-Systemising theory of sex differences and the Extreme Male Brain theory of autism.

READ MORE

The Role of Oligodendrocytes in MS

News

Mapping of a certain group of cells, known as oligodendrocytes, in the central nervous system of a mouse model of multiple sclerosis (MS), shows that they might have a significant role in the development of the disease. The discovery can lead to new therapies targeted at other areas than just the immune system.

READ MORE

Shortage of Gene Silencing Molecules Linked to Pediatric Brain Tumor Development

News

Researchers have added to evidence that a shortage of specific tiny molecules that silence certain genes is linked to the development and growth of pediatric brain tumors known as low-grade gliomas.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE